Molbio Diagnostics IPO GMP: Market analysts have recommended subscribing to the issue, noting that Molbio Diagnostics’ valuations are broad...

Molbio Diagnostics aims to secure ₹200 crore to enhance its capital expenditures through a new issuance of shares. In tandem, the firm inte...

Molbio Diagnostics raised Rs 281 crore from anchor investors, including World Bank Group's IFC and HDFC Mutual Fund, ahead of its Rs 940 cr...

India’s primary market is set for a busy week, with nine companies aiming to raise a combined Rs 7,681 crore through IPOs across the mainbo...

Molbio Diagnostics has successfully attracted Rs 281.5 crore from anchor investors ahead of its much-anticipated initial public offering. T...

Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner ₹12,000-13,000 crore through IPOs i...

A large number of top executives have moved from unicorns to Series A and B firms or even down the chain in recent months – a move that ref...

"We continue to advise allotted investors to book profits, and if anyone wishes to buy, they should wait and watch for the counter as marke...

Integrated electronic manufacturing services provider Cyient DLM made a strong debut on the stock exchanges, with shares listing at a premi...

The grey market premium (GMP) of Cyient DLM is around Rs 150-155 in the unlisted market. If we consider the upper price band of Rs 265, the...

Cyient DLM's initial public offering (IPO) received a strong response as the overall issue was subscribed 7.6 times. The retail category ha...

Cyient DLM has initiated its initial public offering for subscription, with a price band of INR250-265 ($3.36-$3.55) and a proposed market ...

Listed IT company Cyient is the promoter of the company. Given the rich valuation, high risk-taking investors may consider the IPO to parti...

However, many of the SaaS unicorns reached the coveted $1-billion valuation on the back of inflated price-to-valuation ratios, Orios managi...